Cargando…

CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products

Ascaris spp. is a major health problem of humans and animals alike, and understanding the immunogenicity of its antigens is required for developing urgently needed vaccines. The parasite-secreted products represent the most relevant, yet complex (>250 proteins) antigens of Ascaris spp. as definin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebner, Friederike, Morrison, Eliot, Bertazzon, Miriam, Midha, Ankur, Hartmann, Susanne, Freund, Christian, Álvaro-Benito, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083960/
https://www.ncbi.nlm.nih.gov/pubmed/32218997
http://dx.doi.org/10.1038/s41541-020-0171-z
_version_ 1783508633089212416
author Ebner, Friederike
Morrison, Eliot
Bertazzon, Miriam
Midha, Ankur
Hartmann, Susanne
Freund, Christian
Álvaro-Benito, Miguel
author_facet Ebner, Friederike
Morrison, Eliot
Bertazzon, Miriam
Midha, Ankur
Hartmann, Susanne
Freund, Christian
Álvaro-Benito, Miguel
author_sort Ebner, Friederike
collection PubMed
description Ascaris spp. is a major health problem of humans and animals alike, and understanding the immunogenicity of its antigens is required for developing urgently needed vaccines. The parasite-secreted products represent the most relevant, yet complex (>250 proteins) antigens of Ascaris spp. as defining the pathogen-host interplay. We applied an in vitro antigen processing system coupled to quantitative proteomics to identify potential CD4(+) T(h) cell epitopes in Ascaris-secreted products. This approach considerably restricts the theoretical list of epitopes using conventional CD4(+) T(h) cell epitope prediction tools. We demonstrate the specificity and utility of our approach on two sets of candidate lists, allowing us identifying hits excluded by either one or both computational methods. More importantly, one of the candidates identified experimentally, clearly demonstrates the presence of pathogen-reactive T cells in healthy human individuals against these antigens. Thus, our work pipeline identifies the first human T cell epitope against Ascaris spp. and represents an easily adaptable platform for characterization of complex antigens, in particular for those pathogens that are not easily amenable for in vivo experimental validation.
format Online
Article
Text
id pubmed-7083960
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70839602020-03-26 CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products Ebner, Friederike Morrison, Eliot Bertazzon, Miriam Midha, Ankur Hartmann, Susanne Freund, Christian Álvaro-Benito, Miguel NPJ Vaccines Brief Communication Ascaris spp. is a major health problem of humans and animals alike, and understanding the immunogenicity of its antigens is required for developing urgently needed vaccines. The parasite-secreted products represent the most relevant, yet complex (>250 proteins) antigens of Ascaris spp. as defining the pathogen-host interplay. We applied an in vitro antigen processing system coupled to quantitative proteomics to identify potential CD4(+) T(h) cell epitopes in Ascaris-secreted products. This approach considerably restricts the theoretical list of epitopes using conventional CD4(+) T(h) cell epitope prediction tools. We demonstrate the specificity and utility of our approach on two sets of candidate lists, allowing us identifying hits excluded by either one or both computational methods. More importantly, one of the candidates identified experimentally, clearly demonstrates the presence of pathogen-reactive T cells in healthy human individuals against these antigens. Thus, our work pipeline identifies the first human T cell epitope against Ascaris spp. and represents an easily adaptable platform for characterization of complex antigens, in particular for those pathogens that are not easily amenable for in vivo experimental validation. Nature Publishing Group UK 2020-03-20 /pmc/articles/PMC7083960/ /pubmed/32218997 http://dx.doi.org/10.1038/s41541-020-0171-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Brief Communication
Ebner, Friederike
Morrison, Eliot
Bertazzon, Miriam
Midha, Ankur
Hartmann, Susanne
Freund, Christian
Álvaro-Benito, Miguel
CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products
title CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products
title_full CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products
title_fullStr CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products
title_full_unstemmed CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products
title_short CD4(+) T(h) immunogenicity of the Ascaris spp. secreted products
title_sort cd4(+) t(h) immunogenicity of the ascaris spp. secreted products
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083960/
https://www.ncbi.nlm.nih.gov/pubmed/32218997
http://dx.doi.org/10.1038/s41541-020-0171-z
work_keys_str_mv AT ebnerfriederike cd4thimmunogenicityoftheascarissppsecretedproducts
AT morrisoneliot cd4thimmunogenicityoftheascarissppsecretedproducts
AT bertazzonmiriam cd4thimmunogenicityoftheascarissppsecretedproducts
AT midhaankur cd4thimmunogenicityoftheascarissppsecretedproducts
AT hartmannsusanne cd4thimmunogenicityoftheascarissppsecretedproducts
AT freundchristian cd4thimmunogenicityoftheascarissppsecretedproducts
AT alvarobenitomiguel cd4thimmunogenicityoftheascarissppsecretedproducts